Rhode Island Kidney Care Connection
Furthering Kidney Health for Patients
with Diabetes
|
We Need Your Help ...
We have enjoyed bringing you this newsletter over the past year and hope you have found value in the content. Please take a few minutes to share your thoughts to help us continue to provide you with a quality product. Please click here to provide your feedback. |
Minor Kidney Damage in People with Type 1 Diabetes Leads to Increased Mortality
Science Daily: June 26, 2010
People with type 1 diabetes who have early and asymptomatic kidney damage, as indicated by small amounts of protein in the urine, are six times more likely to die compared to the general population, say researchers at the University of Pittsburgh Graduate School of Public Health. Their study, being presented at the 70th Scientific Sessions of the American Diabetes Association, also found that when kidneys remained normal over time, people with type 1 diabetes had no greater risk of death than their healthy counterparts. To view the full article, click here. |
New ONTARGET Analysis:
Monitor Albuminuria to Predict
CV Risk, Death
Medscape Today: July 8, 2010
A new analysis of the large ONTARGET trial presented at the recent European Society of Hypertension (ESH) European Meeting on Hypertension 2010 has shown that big changes in albuminuria predict cardiovascular and renal outcomes and mortality, independent of baseline albuminuria [1].
"The message to general practitioners is that albuminuria is worthwhile to monitor, because a change in albuminuria tells the physician whether the patient has an increased or decreased risk of cardiovascular and renal events and of actually dying. It is a protein that indicates serious consequences," said Dr. Roland E. Schmieder (University of Erlangen, Germany), who presented the findings during a hotline session. To sign in and view the full article, click here. |
Atorvastatin Beats Rosuvastatin in Protecting Kidneys in Diabetic and Nondiabetic Patients Results of two (2) related trials investigating the effects of statins on urinary protein excretion and kidney function found atorvastatin (ATV) protective and rosuvastatin (RSV) unprotective, and possibly harmful, in diabetic and nondiabetic patients.
High-dose ATV significantly reduced proteinuria and did not affect renal function, whereas RSV was associated with a significant decline in function and had no effect on proteinuria, according to results of the PLANET trials, reported in a late-breaking trials session at the XLVII European Renal Association-European Dialysis and Transplant Association Congress by Dick de Zeeuw, MD, PhD, a clinical pharmacologist and clinical trialist at the University Medical Center in Groningen, The Netherlands. To view the full article, click here. |
|
This material was prepared by Quality Partners of Rhode
Island, the Quality Improvement Organization for Rhode Island, under
contract with the Centers for Medicare & Medicaid Services (CMS),
an agency of the U.S. Department of Health and Human Services.
|
|
|
|
|
|
Resources
The POINT is a valuable resource that can help you link your patients with information and assistance on an array of services that are available to seniors, adults with disabilities, and their caregivers. |
|
Events &
Continuing Education
Opportunities
American Kidney Fund CME: Identifying Chronic Kidney Disease and Slowing Its Progression
After completing the on-line course, participants will be able to:
- Describe the demographics of the CKD population
- List the medical interventions needed to prevent or slow the progression of CKD
- Recognize the importance of early referral to nephrologists
National Kidney Foundation CME: Nutrition and CKD: First Line of Defense
To access this on-line activity, click here. |
|
|
